Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald S Falchook

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Journal of Immunotherapy and Precision Oncology|June 27, 2022
Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor CancersMartin V Nguyen, Lydia Loof, Gerald S Falchook
Gynecologic Oncology|January 1, 2008
Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastasesGerald S Falchook, Robert A Wolff, Gauri R Varadhachary
Journal of Immunotherapy and Precision Oncology|January 15, 2025
Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A ReviewIsabelle House, Mari Valore-Caplan, Elijah Maris, et al.
Head & Neck|July 16, 2013
Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatmentGerald S Falchook, Scott M Lippman, Christel C Bastida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United StatesGerald S Falchook, Clinton M Malone, Scott Upton, et al.
Journal of Immunotherapy and Precision Oncology|December 31, 2025
AXL Inhibitors in Oncology Clinical Trials: A ReviewEthan Quach, Farahnoz Sanginova, Anish Cheruku, et al.
Cancer Medicine|February 5, 2021
A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite-stable metastatic colorectal cancerManish R Patel, Gerald S Falchook, Kensuke Hamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatmentGerald S Falchook, Filip Janku, Anne S Tsao, et al.
Journal for Immunotherapy of Cancer|November 24, 2016
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810Gerald S Falchook, Rom Leidner, Elizabeth Stankevich, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastasesSean S Garcia, Johnique T Atkins, Gerald S Falchook, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Journal of Immunotherapy and Precision Oncology|June 27, 2022
Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor CancersMartin V Nguyen, Lydia Loof, Gerald S Falchook
Gynecologic Oncology|January 1, 2008
Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastasesGerald S Falchook, Robert A Wolff, Gauri R Varadhachary
Journal of Immunotherapy and Precision Oncology|January 15, 2025
Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A ReviewIsabelle House, Mari Valore-Caplan, Elijah Maris, et al.
Head & Neck|July 16, 2013
Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatmentGerald S Falchook, Scott M Lippman, Christel C Bastida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2003
Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United StatesGerald S Falchook, Clinton M Malone, Scott Upton, et al.
Journal of Immunotherapy and Precision Oncology|December 31, 2025
AXL Inhibitors in Oncology Clinical Trials: A ReviewEthan Quach, Farahnoz Sanginova, Anish Cheruku, et al.
Cancer Medicine|February 5, 2021
A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite-stable metastatic colorectal cancerManish R Patel, Gerald S Falchook, Kensuke Hamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatmentGerald S Falchook, Filip Janku, Anne S Tsao, et al.
Journal for Immunotherapy of Cancer|November 24, 2016
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810Gerald S Falchook, Rom Leidner, Elizabeth Stankevich, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastasesSean S Garcia, Johnique T Atkins, Gerald S Falchook, et al.
Pageof 14